The Biden administration has granted approval to Florida's plan to import cheaper prescription drugs from Canada, signaling a major development in the ongoing battle for affordable medications. The Food and Drug Administration (FDA) made the decision on Friday, setting forth the condition that Florida's health department must provide quarterly reports to the agency. These reports will include information on cost savings as well as any safety and quality concerns.
FDA Commissioner Robert Califf emphasized the agency's commitment to collaborating with states and tribes in developing importation proposals. However, he stressed that such proposals should demonstrate substantial cost savings for consumers without compromising the safety or effectiveness of the drugs being imported.
This decision from the FDA marks the latest development in a longstanding dispute between states and the federal government concerning the importation of cheaper drugs. The pharmaceutical industry has wasted no time in pushing back against the FDA's announcement.
Stephen Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), labeled the FDA's approval of Florida's plan as "reckless." He expressed concerns over the safety of importing unapproved medicines, whether from Canada or any other country, cautioning that it poses a serious danger to public health. Ubl emphasized the need to ensure patient access to necessary medications but urged politicians to avoid interfering with Americans' healthcare.
PhRMA is considering all available options to prevent this policy from impacting patients negatively. The group had previously filed a lawsuit against the FDA in 2020 regarding a similar plan under the Trump administration, but the lawsuit was dismissed later on.
President Joe Biden's executive order issued in July 2021 showed support for FDA collaboration with states on importing drugs from Canada. Nonetheless, in August 2022, Florida sued the FDA, arguing that the agency was obstructing its drug importation plan.
Currently, states including Colorado, North Dakota, and Vermont have enacted laws allowing drug importation, according to the National Conference of State Legislatures. Over five of these states have sought FDA approval for their respective plans, according to the conference's data.
Florida's successful bid to import cheaper medications from Canada could potentially pave the way for other states to follow suit. With the ongoing push for affordable healthcare and medication, the outcome of this decision will likely have significant implications for the future of drug importation in the United States.